Bixiye
QP98-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Fintepla® (fenfluramine) PA with QL
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020
Natiijooyinka Raadinta
Soo bandhiga 1831 - 1840 ee natiijooyinka 4296
Bixiye
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020
Bixiye
QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020
Bixiye
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020
Bixiye
QP94-20 Commercial Pharmacy Benefit Exclusion for Condylox®, Lyumjev™, Veregen® and Zilxi™
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020
Bixiye
QP102-20 Introducing eviCore’s new intelliPath® Technology
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020
Bixiye
P76-20 2021 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2020
Bixiye
2020 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2020